To study the renal disease in newly diagnosed HIV infected hospitalized patients and to look for possible correlation of CD4 count with prevalence of renal disease. Materials and Methods: The prospective study was conducted in Department of Medicine/Endocrinology in tertiary care health center in western U.P during the study period of one year. The patients were evaluated clinically and biochemically after obtaining the informed consent. Result: The study was conducted on 100 HIV/AIDS patients, out of which 68 (68%) were males and 32 (32%) females with a Highest incidence of HIV/AIDS (51%) in the age group of 25-35 years. Microalbuminuria was present in 20 (20%) HIV patients with majority (60%) being in the age group 25-35 years. Prevalence of microalbuminuria among males was 55% and among females 45%. Microalbuminuria was further evaluated by calculating the ratio of microalbumin to urinary creatinine, 83% patient had ratio >10 mg/mmol and 17% had this ratio <10 mg/mmol. The ratio of microalbumin to urinary creatinine >10 mg/mmol was 60% in age 25-35 year, 25% in the age group of 36-45 year followed by 15% in the age group of 45-55 year patients. Chi-square test was used to calculate the signifi cance of the correlation between CD4 counts with the presence of microalbuminuria in HIV patients. There was a signifi cant correlation between CD4 count <200/μL and presence of microalbuminuria (p =0006). Statistically signifi cant proteinuria (30-300 mg/24 hour) was found in 15 patients with CD4 count <200/μL of those patients found positive for microalbuminuria. Protein/ creatinine ratio was <0.2 in 18 patients, 2 had ratio in the range of 0.2-3.5 and none in the nephrotic range (>3.5). Conclusion: Study evaluation shows that there is statistically signifi cant microalbuminuria in HIV/AIDS infected patients and this is more prevalent in patients with CD4 count <200/μL as compared to patients with CD4 count >200/μL in keeping with previous studies. The routine laboratory measurements like serum creatinine and proteinuria fail to recognize the patients with early renal involvement. In view of the high prevalence of renal dysfunction among hospitalized HIV infected patients, it is recommended to use microalbuminuria as routine screening tests in those who are HIV positive.
INTRODUCTION
Since the detection of fi rst HIV patient in 1983 HIV and AIDS has spread very rapidly to take the shape of pandemic. According to the UNAIDS report 2013, there were 35.3 (32.2-38.8) million patients living with HIV across the globe. 1 The number of new infection showed a reduction of 33.3% in 2012 from 2001. The mortality has declined in 2012 to 1.6 (1.4-1.9) million as compared to 2.3 (2.1-2.6) million in 2005. 1 The Government of India estimated that about 2.40 million Indians were living with HIV (1.93-3.04 million) with an adult prevalence of 0.31% (2009).
2 Children (<15 yrs) accounted for 3.5% of all infections. While 83% were the in age groups 15-49 years. Of all HIV infections, 39% (930,000) were among women. India's highly heterogeneous epidemic was largely concentrated in only few states -In the industrialized south and west, and in the north-east. Four high prevalence states of South India (Andhra Pradesh-500,000, Maharashtra-420,000, Karnataka-250,000, Tamil Nadu-150,000) accounted for 55% of all HIV infections in the country.
2 West Bengal, Gujarat, Bihar and Uttar Pradesh were estimated to have more than 100,000 PLHA each and together account for another 22% of HIV infections in India.
2
Survival among persons with HIV infection has improved signifi cantly over the last decade. 3 Concurrent with the improvements in morbidity and mortality, there has been an increase in deaths among HIV infected patients attributed to kidney disease. 3 As a result, there has been increasing focus in research and clinical care on kidney conditions, which has improved our understanding of their pathogenesis as long-term complications of HIV infection. Among HIV infected persons, the presence of microalbuminuria has been linked to CKD (chronic kidney disease), ESRD (end stage renal disease), new AIDS defi ning illness and mortality. 4 The spectrum of renal involvement in HIV positive patients ranges from mild fl uid and electrolyte disorders to acute renal failure and HIV associated nephropathy (HIVAN) leading thereby to end-stage renal disease (ESRD). 4 HIVAN is the third leading cause of ESRD in AfricanAmericans between the age of 20 and 64 and the most common cause of ESRD in HIV-1 seropositive patients. 5 Patients typically present with renal insufficiency accompanied by proteinuria that is usually in the nephrotic range. 5 Despite the presence of heavy proteinuria, peripheral edema is uncommon. Hypertension is also surprisingly rare in most patients of HIVAN.
There is scarcity of Indian studies as far as the renal spectrum in HIV is concerned.
Aims and Objectives
This is a cross section observational study conducted with the following objectives: 1. To study the presence of renal diseases in newly diagnosed HIV infected hospitalized patients. 2. To look for possible correlation of CD4 count with prevalence of renal disease.
MATERIALS AND METHODS
The present cross section observational study was conducted on 100 HIV infected hospitalized patients in a tertiary care hospital over a period of one year. A written and informed consent was taken from the subjects prior to the study. Screening tests employed were Direct Sandwich Elisa Test Method (3 rd generation) and Combaids-RS Test for Detecting HIV-1 and 2. The subjects underwent various laboratory investigations like complete blood count, urine examination, urea, creatinine, Serum proteins, Blood Urea, blood sugar, 24 hr, Chest X-Ray, USG Abdomen KUB, Microalbumin urine test (MICRAL test), a semiquantitative immunological method for the detection of urinary albumin, was used in this study. Glomerular filtration rate (GFR) was derived from creatinine clearance calculated by Cockcroft Gualt formula. CD4 T lymphocyte count was measured by using BD True COUNT Method. Inclusion criteria were age >25 years, absence of severe cardiac disease, absence of urinary tract infection, no drug use that could interfere in urinary creatinine excretion, absence of pregnancy, non diabetic HIV patients. Exclusion criteria were patient not giving consent for the study, mentally subnormal, and not fulfi lling inclusion criteria.
Statistical Analysis
Continuous data were summarized as Mean ± SD while discrete (categorical) in number and percentage. Continuous two independent groups were compared by parametric independent Student's test and the significance of parametric t test was also validated with nonparametric alternative Mann-Whitney U test, where appropriate. Discrete (categorical) groups were compared by chi-square (χ 2 ) test. Predictors of fi nal outcome were evaluated by using multivariate logistic regression analysis. A two-sided (α=2) p values less than 0.05 (p<0.05) was considered statistically signifi cant. All analyses were performed on STATISTICA data analysis software system version 6.0 (for Windows). Tulsa, OK: StatSoft.Inc; 2000.
RESULTS
The present study was conducted on 100 HIV/AIDS patients, out of which 73 (73%) were males and 27 (27%) females. More than half (56%) of the patients were in the age group 25-35 years ( Table 1 ). The distribution of biochemical parameters is depicted in the Table 2 . The average Hb was 10.51 (±2.02) whereas the mean serum creatinine was 1.28 (±0.61). The prevalence of microalbuminuria was found to be 25% (Table 3) The distribution of HIV/AIDS patients according to EGFR staging is depicted in the Table 4 . About one third of the patients were in stage II (37%) and III (35%). However, 15% were in stage IV and 13% in stage I. The association of microalbuminuria with age of the patients is presented in the Table 5 . The prevalence of microalbuminuria was insignifi cantly (p>0.05) higher among the patients of 36-45 years (27.6%) compared with 25-35 (26.8%) and >45 (13.3%) years. The correlation of CD4 cell counts with the presence of microalbunuria is given in the Table 6 . The prevalence of microalbunuria was among 35.7% in the patients of CD4 cell count <200/l and it were 17.2% in the patients of CD4 cell count ≥200/l. However, this correlation was statistically signifi cant (p=0.03).
There was negative poor correlation between CD4 with serum creatinine and 24 hour urine protein (Table 7) .
DISCUSSION
HIV associated nephropathy; the most common renal disease in HIV patients was fi rst described in 1984. 6, 7 Most patients present with nephrotic syndrome, progressive loss of renal function and without treatment progress to ESRD within months. 8 The present study was undertaken to detect the prevalence of microalbuminuria in patients who were positive for HIV irrespective of the stage of illness. Out of these, 73% were males and 27% females with male: female ratio of 2.7:1. In a large Indian study done in Pune involving 2801 subjects over a period of 2 years, Ghate et al. 9 reported male:female ratio of 2.22:1. In another Indian study, Kumarasamy et al. 10 reported that out of 594 HIV/AIDS patients, 72.9% were males and 27.1% females, male: female ratio being 2.6:1, which is consistent with the present study.
Highest incidence of HIV/AIDS (51%) was found in the age group of 25-35 years in the present study, followed by 29% in 36-45 years age group. When the two age groups were clubbed from age 26 to 45 years, the incidence came out to be 81.47%. In a study by Ghate et al, 6 88.1% HIV positive patients were in the age group of 21 to 40 years, which is almost consistent with the present study. Another Indian Study done in Jammu was conducted on 108 HIV/AIDS patients, out of which 77 (71%) were males and 31 (29%) females with a male: female ratio of 2.48:1 (Table 1) . 11 Highest incidence of HIV/AIDS (55.56%) was found in the age group of 26-35 years, followed by 25.93% in 36-45 years.
In our study, prevalence of microalbuminuria was observed in 25% patients after all 100 HIV/AIDS patients were screened for the presence of microalbuminuria. In a cross sectional study Lynda et al. demonstrated microalbuminuria in 11% of HIV infected patients while other past three studies showed striking high prevalence of microalbuminuria of 19%, 30% and 34% in HIV infected patients. 12 However, Busch et al 8 found 13% of the 90 HIV infected patients with an albumin excretion >20 mg/liter; Verma et al 13 reported prevalence of 17.6% among 142 HIV patients over a 4 year period. All 20 patients who tested positive for presence of microalbuminuria were further evaluated by 24 hour urinary protein evaluation and only 2 patients had proteinuria in the range of 30-300 mg/24 hour. There was no patient with proteinuria >300 mg/24 hour (nephrotic range). Further evaluation by urinary microalbumin to creatinine ratio on a spot sample of urine supported present study's fi nding of microalbuminuria in these patients. Seventeen patients had microalbumin: creatinine ratio >10 mg/mmol and 3 had this ratio <10 mg/mmol. Mean CD4 cell count was calculated in patients with positive microalbuminuria test and 10 patients had mean CD4 cell counts >200/μL, while 15 patients had mean CD4 counts <200/μl, average CD4 cell counts being 221.27/μl and 119.89/μl respectively. In previous studies also, Szczech et al 14 found decreased CD4 lymphocyte cell counts and increased HIV-RNA levels as predictors of proteinuria. Atta et al 15 found that patients with HIV associated nephropathy had a signifi cantly lower CD4 cell counts (158/μl versus 349/μl; p < 0.01) at the time of biopsy. Subclinical dysfunction is not uncommon in HIV positive patients and many of these patients with incipient nephropathy are not detected by routine laboratory tests.
HIV infection appears to be a risk factor for developing chronic kidney disease. Even in patients with normal kidney function, the presence of proteinuria may indicate early kidney disease. If initial urine analysis results are normal, annual follow-up urine analysis are recommended to screen for newly developed kidney damage for the following groups, which are at higher risk for the development of proteinuria and poor renal outcome -African-American persons, patients with diabetes, patients with hypertension, patient with hepatitis C virus co-infection and patients with HIV-RNA levels >4000 copies/L or absolute CD4 lymphocyte counts <200/μL. An estimate of creatinine clearance for GFR is also recommended annually to screen for renal dysfunction that may develop overtime and that may herald worse overall prognosis. Recent reports have suggested that the baseline presence of proteinuria with or without concomitant elevations in the serum creatinine level is a sensitive prognosticator of the eventual development of chronic kidney disease. 11 Main limitations of the present study were that fi rstly HIV-RNA levels would not be performed due to the fi nancial constraints and lack of the facility in the present institution. Secondly, those patients whose urine tested for positive for microalbuminuria could not be further evaluated due to absence of proper set-up for renal biopsy in the hospital.
